Cambridge, MA, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and ...
Given its acquisition spree over the past few years, Travel Leaders Network's dominance in the consortia category should come as no surprise. Still, the growth in its dominance over the past three ...
The seminar proved to be a significant milestone in advancing library networking and automation in the northeastern region, fostering future collaborations and setting the stage for continued progress ...